Symbols / MENS Stock $2.27 -0.44% Jyong Biotech Ltd.
MENS (Stock) Chart
About
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Stock Fundamentals
Scroll to Statements| Market Cap | 172.58M | Enterprise Value | 181.08M | Income | -2.94M | Sales | — | Book/sh | -0.31 | Cash/sh | 0.24 |
| Dividend Yield | — | Payout | 0.00% | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | -7.25 | P/C | — | EV/EBITDA | -100.43 | EV/Sales | — |
| Quick Ratio | 0.62 | Current Ratio | 0.62 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | -0.04 | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | -5.44% | ROE | — | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 74.23M | Shs Float | 27.63M | Short Float | 0.57% |
| Short Ratio | 1.12 | Short Interest | — | 52W High | 67.00 | 52W Low | 1.43 | Beta | — | Avg Volume | 275.83K |
| Volume | 70.25K | Target Price | — | Recom | None | Prev Close | $2.28 | Price | $2.27 | Change | -0.44% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.27
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
$2.27
Low
—
High
—
Mean
—
- MENS Stock Price, Quote & Chart | JYONG BIOTECH LTD (NASDAQ:MENS) - ChartMill ue, 21 Apr 2026 07
- Men’s Wearhouse owner aims to rejoin the stock market - Retail Dive Wed, 22 Apr 2026 15
- Luke Stock Earns Big Ten Men's Golfer of the Week Award - USC Athletics hu, 02 Apr 2026 07
- Men's Basketball Announces Signing of Rashaad Williams - Georgia Southern University Athletics hu, 16 Apr 2026 15
- Mens Tennis (stock) - Western Herald Sat, 18 Apr 2026 15
- Who Backs Jyong Biotech (MENS) Stock (Risk Aversion) 2026-04-20 - Investment Picks - Cổng thông tin điện tử tỉnh Tây Ninh Mon, 20 Apr 2026 15
- Jyong Biotech (NASDAQ:MENS) Stock Price Down 19.3% - Here's What Happened - MarketBeat ue, 16 Dec 2025 08
- Pac-12 Conference and The Big West Announce Collaborative Men’s Soccer Partnership to Strengthen Opportunities in the West - pac-12.com Mon, 30 Mar 2026 07
- Exploring Jyong Biotech’s (NasdaqGM:MENS) Valuation Following Recent Share Price Volatility - Yahoo Finance hu, 20 Nov 2025 08
- Director of Jyong Biotech (MENS) files Form 3 showing 3,000 common shares - Stock Titan Wed, 01 Apr 2026 07
- MENS Jyong Biotech drops 3.69% on weak Q1 2025 earnings marked by zero revenue and negative EPS. - Shared Momentum Picks - UBND thành phố Hải Phòng hu, 23 Apr 2026 02
- After the recent decline, Jyong Biotech Ltd. (NASDAQ:MENS) CEO Fu-Feng Kuo's holdings have lost 33% of their value - simplywall.st Mon, 29 Dec 2025 08
- MENS Stock Price and Chart — NASDAQ:MENS - TradingView ue, 17 Jun 2025 21
- Jyong Biotech (MENS) Management Strategy | Q1 2025: Earnings Report - Pre Earnings - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 02
- Jyong Biotech (MENS) CEO Kuo reports 25,349,500-share indirect stake on Form 3 - Stock Titan Wed, 08 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
2.06
-26.49%
|
2.80
-1.13%
|
2.83
+17.68%
|
2.40
|
| Research And Development |
|
0.93
-13.45%
|
1.07
-16.98%
|
1.29
-17.25%
|
1.56
|
| Selling General And Administration |
|
1.13
-34.59%
|
1.73
+12.15%
|
1.54
+82.13%
|
0.84
|
| Selling And Marketing Expense |
|
0.04
-6.38%
|
0.05
+0.00%
|
0.05
-12.96%
|
0.05
|
| General And Administrative Expense |
|
1.08
-35.38%
|
1.68
+12.53%
|
1.49
+88.62%
|
0.79
|
| Other Gand A |
|
1.08
-35.38%
|
1.68
+12.53%
|
1.49
+88.62%
|
0.79
|
| Total Expenses |
|
2.06
-26.49%
|
2.80
-1.13%
|
2.83
+17.68%
|
2.40
|
| Operating Income |
|
-2.06
+26.49%
|
-2.80
+1.13%
|
-2.83
-17.68%
|
-2.40
|
| Total Operating Income As Reported |
|
-2.06
+26.49%
|
-2.80
+1.13%
|
-2.83
-17.68%
|
-2.40
|
| EBITDA |
|
-1.86
+46.99%
|
-3.52
+38.77%
|
-5.74
-77.17%
|
-3.24
|
| Normalized EBITDA |
|
-1.86
+46.99%
|
-3.52
+38.77%
|
-5.74
-77.17%
|
-3.24
|
| Reconciled Depreciation |
|
0.12
-5.51%
|
0.13
+3.25%
|
0.12
+0.82%
|
0.12
|
| EBIT |
|
-1.98
+45.54%
|
-3.64
+37.89%
|
-5.87
-74.40%
|
-3.36
|
| Net Income |
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
-57.93%
|
-4.20
|
| Pretax Income |
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
-57.93%
|
-4.20
|
| Net Non Operating Interest Income Expense |
|
-1.03
-46.65%
|
-0.70
+7.76%
|
-0.76
+8.32%
|
-0.83
|
| Interest Expense Non Operating |
|
1.03
+36.72%
|
0.76
-1.05%
|
0.77
-8.38%
|
0.83
|
| Net Interest Income |
|
-1.03
-46.65%
|
-0.70
+7.76%
|
-0.76
+8.32%
|
-0.83
|
| Interest Expense |
|
1.03
+36.72%
|
0.76
-1.05%
|
0.77
-8.38%
|
0.83
|
| Interest Income Non Operating |
|
0.01
-87.50%
|
0.06
+1020.00%
|
0.01
-16.67%
|
0.01
|
| Interest Income |
|
0.01
-87.50%
|
0.06
+1020.00%
|
0.01
-16.67%
|
0.01
|
| Other Income Expense |
|
0.07
+107.21%
|
-0.90
+70.34%
|
-3.04
-215.13%
|
-0.96
|
| Other Non Operating Income Expenses |
|
0.07
+107.21%
|
-0.90
+70.34%
|
-3.04
-215.13%
|
-0.96
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
-57.93%
|
-4.20
|
| Net Income From Continuing Operation Net Minority Interest |
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
-57.93%
|
-4.20
|
| Net Income From Continuing And Discontinued Operation |
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
-57.93%
|
-4.20
|
| Net Income Continuous Operations |
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
-57.93%
|
-4.20
|
| Normalized Income |
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
-57.93%
|
-4.20
|
| Net Income Common Stockholders |
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
-57.93%
|
-4.20
|
| Diluted EPS |
|
-0.04
+31.39%
|
-0.06
+33.63%
|
-0.09
-57.93%
|
-0.06
|
| Basic EPS |
|
-0.04
+31.39%
|
-0.06
+33.63%
|
-0.09
-57.93%
|
-0.06
|
| Basic Average Shares |
|
76.03
+0.00%
|
76.03
+0.00%
|
76.03
+0.00%
|
76.03
|
| Diluted Average Shares |
|
76.03
+0.00%
|
76.03
+0.00%
|
76.03
+0.00%
|
76.03
|
| Diluted NI Availto Com Stockholders |
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
-57.93%
|
-4.20
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
6.37
-22.82%
|
8.25
-5.68%
|
8.74
-7.28%
|
9.43
|
| Current Assets |
|
0.21
-88.80%
|
1.84
-25.33%
|
2.46
-6.99%
|
2.65
|
| Cash Cash Equivalents And Short Term Investments |
|
0.10
-44.63%
|
0.18
-78.20%
|
0.81
-65.95%
|
2.38
|
| Cash And Cash Equivalents |
|
0.10
-44.63%
|
0.18
-75.35%
|
0.72
+30.31%
|
0.55
|
| Cash Equivalents |
|
0.10
-44.89%
|
0.18
-75.38%
|
0.71
+30.00%
|
0.55
|
| Cash Financial |
|
0.00
+0.00%
|
0.00
-66.67%
|
0.00
+200.00%
|
0.00
|
| Other Short Term Investments |
|
—
|
0.00
-100.00%
|
0.09
-94.87%
|
1.83
|
| Restricted Cash |
|
0.00
-99.81%
|
1.56
+0.58%
|
1.56
|
0.00
|
| Other Current Assets |
|
0.10
+8.25%
|
0.10
+2.11%
|
0.10
-63.88%
|
0.26
|
| Total Non Current Assets |
|
6.16
-3.89%
|
6.41
+2.02%
|
6.28
-7.40%
|
6.78
|
| Net PPE |
|
3.19
-10.10%
|
3.54
-40.92%
|
6.00
-11.47%
|
6.78
|
| Gross PPE |
|
4.76
-6.74%
|
5.11
-31.24%
|
7.43
-9.73%
|
8.23
|
| Accumulated Depreciation |
|
-1.58
-0.90%
|
-1.56
-9.46%
|
-1.43
+1.59%
|
-1.45
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
0.95
-6.67%
|
1.02
+0.39%
|
1.02
-9.77%
|
1.13
|
| Buildings And Improvements |
|
2.48
-6.60%
|
2.65
+0.38%
|
2.64
-9.74%
|
2.93
|
| Machinery Furniture Equipment |
|
0.13
-6.99%
|
0.14
+0.70%
|
0.14
-9.55%
|
0.16
|
| Construction In Progress |
|
0.14
-2.88%
|
0.14
-3.47%
|
0.14
+336.36%
|
0.03
|
| Other Properties |
|
0.93
-7.68%
|
1.00
-69.91%
|
3.33
-14.91%
|
3.92
|
| Leases |
|
0.14
-6.67%
|
0.15
+0.00%
|
0.15
+123.88%
|
0.07
|
| Non Current Deferred Assets |
|
0.93
+29.54%
|
0.72
+161.23%
|
0.28
|
0.00
|
| Other Non Current Assets |
|
2.04
-4.85%
|
2.14
+30528.57%
|
0.01
-12.50%
|
0.01
|
| Total Liabilities Net Minority Interest |
|
42.88
+1.33%
|
42.32
+10.28%
|
38.38
+17.15%
|
32.76
|
| Current Liabilities |
|
12.13
-14.95%
|
14.26
+10.47%
|
12.91
+105.07%
|
6.29
|
| Payables And Accrued Expenses |
|
1.36
+17.04%
|
1.16
+33.41%
|
0.87
-19.94%
|
1.09
|
| Payables |
|
0.04
+91.30%
|
0.02
+187.50%
|
0.01
-83.33%
|
0.05
|
| Accounts Payable |
|
0.00
+50.00%
|
0.00
-50.00%
|
0.00
-91.30%
|
0.05
|
| Current Accrued Expenses |
|
1.32
+15.54%
|
1.14
+31.98%
|
0.86
-17.02%
|
1.04
|
| Current Debt And Capital Lease Obligation |
|
7.44
-8.16%
|
8.10
+3.63%
|
7.82
+50.84%
|
5.18
|
| Current Debt |
|
7.28
-8.66%
|
7.97
+4.24%
|
7.65
+55.04%
|
4.93
|
| Other Current Borrowings |
|
7.28
-8.66%
|
7.97
+4.24%
|
7.65
+55.04%
|
4.93
|
| Current Capital Lease Obligation |
|
0.16
+22.31%
|
0.13
-23.53%
|
0.17
-32.00%
|
0.25
|
| Other Current Liabilities |
|
3.33
-33.40%
|
4.99
+18.40%
|
4.22
+18239.13%
|
0.02
|
| Total Non Current Liabilities Net Minority Interest |
|
30.76
+9.60%
|
28.06
+10.18%
|
25.47
-3.76%
|
26.46
|
| Long Term Debt And Capital Lease Obligation |
|
10.69
+24.51%
|
8.59
+33.51%
|
6.43
-2.62%
|
6.61
|
| Long Term Debt |
|
10.68
+25.33%
|
8.52
+34.85%
|
6.32
+0.93%
|
6.26
|
| Long Term Capital Lease Obligation |
|
0.02
-76.81%
|
0.07
-40.00%
|
0.12
-66.76%
|
0.35
|
| Tradeand Other Payables Non Current |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Other Non Current Liabilities |
|
19.44
+3.13%
|
18.85
+2.38%
|
18.41
-4.27%
|
19.23
|
| Stockholders Equity |
|
-36.52
-7.18%
|
-34.07
-14.99%
|
-29.63
-27.04%
|
-23.32
|
| Common Stock Equity |
|
-36.52
-7.18%
|
-34.07
-14.99%
|
-29.63
-27.04%
|
-23.32
|
| Capital Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Common Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Share Issued |
|
76.03
+0.00%
|
76.03
+0.00%
|
76.03
+0.00%
|
76.03
|
| Ordinary Shares Number |
|
76.03
+0.00%
|
76.03
+0.00%
|
76.03
+0.00%
|
76.03
|
| Additional Paid In Capital |
|
11.80
+0.00%
|
11.80
+0.00%
|
11.80
+0.00%
|
11.80
|
| Retained Earnings |
|
-33.08
-10.04%
|
-30.06
-17.15%
|
-25.66
-34.84%
|
-19.03
|
| Gains Losses Not Affecting Retained Earnings |
|
1.12
+104.56%
|
0.55
-7.12%
|
0.59
+121.80%
|
0.27
|
| Treasury Stock |
|
16.37
+0.00%
|
16.37
+0.00%
|
16.37
+0.00%
|
16.37
|
| Other Equity Adjustments |
|
1.12
+104.56%
|
0.55
-7.12%
|
0.59
+121.80%
|
0.27
|
| Total Equity Gross Minority Interest |
|
-36.52
-7.18%
|
-34.07
-14.99%
|
-29.63
-27.04%
|
-23.32
|
| Total Capitalization |
|
-25.84
-1.13%
|
-25.55
-9.61%
|
-23.31
-36.61%
|
-17.07
|
| Working Capital |
|
-11.92
+4.01%
|
-12.42
-18.91%
|
-10.44
-186.45%
|
-3.65
|
| Invested Capital |
|
-18.56
-5.56%
|
-17.58
-12.23%
|
-15.66
-29.12%
|
-12.13
|
| Total Debt |
|
18.14
+8.65%
|
16.69
+17.12%
|
14.25
+20.88%
|
11.79
|
| Net Debt |
|
17.86
+9.48%
|
16.32
+23.15%
|
13.25
+24.49%
|
10.64
|
| Capital Lease Obligations |
|
0.17
-12.06%
|
0.20
-30.18%
|
0.28
-52.18%
|
0.60
|
| Net Tangible Assets |
|
-36.52
-7.18%
|
-34.07
-14.99%
|
-29.63
-27.04%
|
-23.32
|
| Tangible Book Value |
|
-36.52
-7.18%
|
-34.07
-14.99%
|
-29.63
-27.04%
|
-23.32
|
| Dueto Related Parties Current |
|
0.04
+95.24%
|
0.02
+425.00%
|
0.00
+100.00%
|
0.00
|
| Dueto Related Parties Non Current |
|
0.63
+0.00%
|
0.63
+0.00%
|
0.63
+0.00%
|
0.63
|
| Interest Payable |
|
0.34
+21.63%
|
0.28
+22.61%
|
0.23
+52.32%
|
0.15
|
| Line Of Credit |
|
—
|
—
|
7.17
+50.67%
|
4.76
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-3.62
-39.33%
|
-2.60
+12.45%
|
-2.97
-49.75%
|
-1.98
|
| Cash Flow From Continuing Operating Activities |
|
-3.62
-39.33%
|
-2.60
+12.45%
|
-2.97
-49.75%
|
-1.98
|
| Net Income From Continuing Operations |
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
-57.93%
|
-4.20
|
| Depreciation Amortization Depletion |
|
0.12
-5.51%
|
0.13
+3.25%
|
0.12
+0.82%
|
0.12
|
| Depreciation |
|
0.12
-5.51%
|
0.13
|
—
|
—
|
| Depreciation And Amortization |
|
0.12
-5.51%
|
0.13
+3.25%
|
0.12
+0.82%
|
0.12
|
| Other Non Cash Items |
|
0.76
+37.36%
|
0.55
-7.51%
|
0.60
-29.45%
|
0.85
|
| Change In Working Capital |
|
-1.49
-232.92%
|
1.12
-61.93%
|
2.94
+136.28%
|
1.24
|
| Change In Prepaid Assets |
|
-0.01
-300.00%
|
-0.00
-101.19%
|
0.17
+23.53%
|
0.14
|
| Change In Payables And Accrued Expense |
|
0.17
-42.52%
|
0.29
+243.41%
|
-0.20
-174.28%
|
0.28
|
| Change In Accrued Expense |
|
0.17
-43.24%
|
0.30
+267.23%
|
-0.18
-165.80%
|
0.27
|
| Change In Payable |
|
0.00
+150.00%
|
-0.00
+92.86%
|
-0.03
-500.00%
|
0.01
|
| Change In Account Payable |
|
0.00
+150.00%
|
-0.00
+92.86%
|
-0.03
-233.33%
|
0.02
|
| Change In Other Current Assets |
|
—
|
—
|
0.00
-100.00%
|
0.00
|
| Change In Other Current Liabilities |
|
-1.65
-299.39%
|
0.83
-72.23%
|
2.97
+258.75%
|
0.83
|
| Investing Cash Flow |
|
0.00
-100.00%
|
0.10
-93.18%
|
1.39
+206.50%
|
-1.31
|
| Cash Flow From Continuing Investing Activities |
|
0.00
-100.00%
|
0.10
-93.18%
|
1.39
+206.50%
|
-1.31
|
| Net PPE Purchase And Sale |
|
—
|
0.00
+100.00%
|
-0.25
-79.56%
|
-0.14
|
| Purchase Of PPE |
|
—
|
0.00
+100.00%
|
-0.25
-79.56%
|
-0.14
|
| Capital Expenditure |
|
—
|
—
|
-0.25
-79.56%
|
-0.14
|
| Net Investment Purchase And Sale |
|
0.00
-100.00%
|
0.10
-94.20%
|
1.64
+240.00%
|
-1.17
|
| Purchase Of Investment |
|
—
|
0.00
+100.00%
|
-0.29
+84.08%
|
-1.83
|
| Sale Of Investment |
|
0.00
-100.00%
|
0.10
-95.08%
|
1.93
+190.66%
|
0.66
|
| Financing Cash Flow |
|
1.99
-1.87%
|
2.03
-39.15%
|
3.33
+341.00%
|
-1.38
|
| Cash Flow From Continuing Financing Activities |
|
1.99
-1.87%
|
2.03
-39.15%
|
3.33
+341.00%
|
-1.38
|
| Net Issuance Payments Of Debt |
|
2.20
-10.92%
|
2.47
-31.48%
|
3.61
+367.73%
|
-1.35
|
| Issuance Of Debt |
|
11.67
-1.36%
|
11.83
-3.65%
|
12.28
+117.72%
|
5.64
|
| Repayment Of Debt |
|
-9.46
-1.17%
|
-9.36
-7.94%
|
-8.67
-24.06%
|
-6.99
|
| Long Term Debt Issuance |
|
2.43
+19.79%
|
2.03
+116.22%
|
0.94
+4585.00%
|
0.02
|
| Long Term Debt Payments |
|
-0.07
+70.78%
|
-0.24
+16.49%
|
-0.29
+79.42%
|
-1.41
|
| Net Long Term Debt Issuance |
|
2.36
+32.14%
|
1.78
+176.01%
|
0.65
+146.34%
|
-1.39
|
| Short Term Debt Issuance |
|
9.24
-5.73%
|
9.80
-13.55%
|
11.34
+101.82%
|
5.62
|
| Short Term Debt Payments |
|
-9.39
-3.08%
|
-9.11
-8.79%
|
-8.38
-50.31%
|
-5.57
|
| Net Short Term Debt Issuance |
|
-0.15
-122.17%
|
0.69
-76.71%
|
2.96
+6341.30%
|
0.05
|
| Net Other Financing Charges |
|
-0.21
+52.13%
|
-0.45
-61.23%
|
-0.28
-688.57%
|
-0.04
|
| Changes In Cash |
|
-1.63
-241.84%
|
-0.48
-127.25%
|
1.75
+137.53%
|
-4.67
|
| Effect Of Exchange Rate Changes |
|
-0.01
+87.04%
|
-0.05
-74.19%
|
-0.03
-146.27%
|
0.07
|
| Beginning Cash Position |
|
1.74
-23.39%
|
2.27
+312.70%
|
0.55
-89.32%
|
5.16
|
| End Cash Position |
|
0.10
-94.20%
|
1.74
-23.39%
|
2.27
+312.70%
|
0.55
|
| Free Cash Flow |
|
-3.62
-39.33%
|
-2.60
+19.15%
|
-3.22
-51.67%
|
-2.12
|
| Interest Paid Supplemental Data |
|
0.22
+114.42%
|
0.10
-35.80%
|
0.16
+52.83%
|
0.11
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|